Firefly Neuroscience, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -203.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +1,375.0% | -67.8% | +126.3% | +34.9% | -10.3% | -13.5% | +4.4% | – | |
| – | – | -13.2% | -1.7% | +3,893.1% | -96.6% | +212.7% | -68.8% | +179.2% | +12.6% | +74.8% | -3.3% | – | |
| – | – | -151.3% | – | -836.9% | – | -158.2% | – | – | +18.5% | -281.2% | – | – | |
| – | -100.0% | – | +38.2% | -9.4% | -51.2% | -91.3% | +71.4% | +616.7% | -73.3% | +152.2% | -27.6% | – | |
| – | -58.8% | -66.1% | +38.2% | -50.8% | -14.6% | -90.8% | +33,785.7% | -96.4% | -73.3% | +152.2% | -27.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +28.3% | -56.0% | -221.2% | – | -46.1% | +447.1% | -88.9% | -101.7% | – | +854.4% | +230.7% | – | |
| – | +134.9% | -139.9% | – | – | -33.5% | +1,233.6% | -146.9% | – | – | – | +1,505.0% | – | |
| – | -203.8% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.